Dihydrotanshinone I inhibits PHGDH to suppress serine synthesis and remodel TME in NSCLC
{{output}}
Background: The strategy of limiting the availability of tumor cell phosphoglycerate dehydrogenase (PHGDH) has become a potential treatment for cancer. Modulation of the tumor-derived serine synthesis pathway to reprogram the tum... ...